Your browser doesn't support javascript.
loading
Spironolactone use is associated with improved outcomes in heart failure with mid-range ejection fraction.
Enzan, Nobuyuki; Matsushima, Shouji; Ide, Tomomi; Kaku, Hidetaka; Higo, Taiki; Tsuchihashi-Makaya, Miyuki; Tsutsui, Hiroyuki.
Affiliation
  • Enzan N; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Matsushima S; Department of Cardiovascular Medicine, Kyushu University Hospital, Maidashi 3-1-1, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Ide T; Department of Experimental and Clinical Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kaku H; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Higo T; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Tsuchihashi-Makaya M; Kitasato University School of Nursing, Sagamihara, Japan.
  • Tsutsui H; Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
ESC Heart Fail ; 7(1): 339-347, 2020 02.
Article in En | MEDLINE | ID: mdl-31951680

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Stroke Volume / Registries / Ventricular Function, Left / Heart Failure Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: ESC Heart Fail Year: 2020 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Stroke Volume / Registries / Ventricular Function, Left / Heart Failure Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: ESC Heart Fail Year: 2020 Document type: Article Affiliation country: Country of publication: